OSL oncosil medical ltd

ALL my rejection for Martin Cross & Brian is not simply because...

  1. 4,660 Posts.
    lightbulb Created with Sketch. 568
    ALL my rejection for Martin Cross & Brian is not simply because of their past performance but mainly because OSL currently running on thin cash and the way economy moving across world the best we as OSL shareholder should do is to reduce Board size to save not just some cash but also save 8,000,000 free shares per AGM proxy form.

    Nigel has a big team of senior management from Sirtex who knows HOW TO SELL THEIR PRODUCT. So we don't need a sales man or shareholder consultant.

    OSL biggest issue to me is lack of approved funding in EU not lack of sales man/women. Once funding is approved then without any shareholder consultant board member OSL will be appreciated and new investor will dip in so the need of this time is to employ if needed basis only to those who can help CEO get regulatory fund approval in EU as well in US (HDE approval).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.01
Change
-0.025(2.43%)
Mkt cap ! $14.29M
Open High Low Value Volume
$1.04 $1.05 $1.00 $41.05K 40.86K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.05 1249 1
View Market Depth
Last trade - 15.47pm 20/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.